Literature DB >> 30284230

Hydrogen peroxide-induced mitophagy contributes to laryngeal cancer cells survival via the upregulation of FUNDC1.

L Hui1, H Wu2, T-W Wang3, N Yang2, X Guo2, X-J Jang2.   

Abstract

PURPOSE: The purpose of our study was to investigate an underlying mechanism that hydrogen peroxide-induced mitophagy contributed to laryngeal cancer cells survivals under oxidative stress condition.
METHODS: Tumor tissue and serum samples were collected from patients with laryngeal cancer. The Hep2 cell, a human laryngeal carcinoma cell, was used in in vitro experiments. The levels of lipid peroxidation were analyzed by ELISA. Knockdown of FUNDC1 was performed by RNAi. The changes of target proteins were determined by qRT-PCR and western blot. The cells were analyzed for changes in proliferation using cell counting kit-8 and mitophagy by the mitochondrial membrane potential assay and transmission electron microscopy.
RESULTS: FUNDC1 in laryngeal cancer tissues were relative to the levels of lipid peroxidation in laryngeal cancer patients, which suggested that FUNDC1 was associated with the status of oxidative stress in the laryngeal cancer patients. Hydrogen peroxide significantly induced the elevation of FUNDC1, a mitophagic factor, in a time- and dose-dependent manner in laryngeal cancer cells, which was dependent on ERK signal activation. Knockdown of FUNDC1 by the siRNA attenuated the survival of laryngeal cancer cells under hydrogen peroxide stimulation. Moreover, the elevated FUNDC1 was required for the occurrence of mitophagy under hydrogen peroxide stimulation, which was identified by transmission electron microscopy, the alterations of mitochondrial permeability transition and the specific mitochondrial protein, hsp60. Inhibition of mitophagy with cyclosporine A could also effectively attenuate the laryngeal cancer cells survival under hydrogen peroxide stimulation.
CONCLUSIONS: Hydrogen peroxide upregulated the expression of FUNDC1 through the activation of ERK1/2 signal to trigger a mitophagic response, giving laryngeal cancer cells a befit for survival. These findings suggested that FUNDC1 might be a potential target for the treatment of laryngeal cancer accompanied with high lipid peroxidation status.

Entities:  

Keywords:  Cell survival; FUNDC1; Hydrogen peroxide; Laryngeal cancer; Mitophagy

Mesh:

Substances:

Year:  2018        PMID: 30284230     DOI: 10.1007/s12094-018-1958-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  16 in total

1.  Induction and Detection of Mitophagy.

Authors:  Maria A Yapryntseva; Boris Zhivotovsky; Vladimir Gogvadze
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Mitophagy in carcinogenesis and cancer treatment.

Authors:  Tatiana V Denisenko; Vladimir Gogvadze; Boris Zhivotovsky
Journal:  Discov Oncol       Date:  2021-12-01

Review 3.  Mitophagy in Cancer: A Tale of Adaptation.

Authors:  Monica Vara-Perez; Blanca Felipe-Abrio; Patrizia Agostinis
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

Review 4.  Mitophagy Receptors in Tumor Biology.

Authors:  Yangchun Xie; Jiao Liu; Rui Kang; Daolin Tang
Journal:  Front Cell Dev Biol       Date:  2020-11-11

Review 5.  Mitochondria-Associated Endoplasmic Reticulum Membranes in Breast Cancer.

Authors:  Hongjiao Yu; Chaonan Sun; Qing Gong; Du Feng
Journal:  Front Cell Dev Biol       Date:  2021-01-28

6.  FOXO3a protects glioma cells against temozolomide-induced DNA double strand breaks via promotion of BNIP3-mediated mitophagy.

Authors:  Chuan He; Shan Lu; Xuan-Zhong Wang; Chong-Cheng Wang; Lei Wang; Shi-Peng Liang; Tian-Fei Luo; Zhen-Chuan Wang; Mei-Hua Piao; Guang-Fan Chi; Peng-Fei Ge
Journal:  Acta Pharmacol Sin       Date:  2021-04-20       Impact factor: 6.150

Review 7.  Molecular Mechanisms and Regulation of Mammalian Mitophagy.

Authors:  Vinay Choubey; Akbar Zeb; Allen Kaasik
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

Review 8.  The mitophagy receptor FUN14 domain-containing 1 (FUNDC1): A promising biomarker and potential therapeutic target of human diseases.

Authors:  Weilin Zhang
Journal:  Genes Dis       Date:  2020-09-02

Review 9.  Mitophagy in Diabetic Kidney Disease.

Authors:  Xiaofeng Zhang; Jing Feng; Xia Li; Dan Wu; Qian Wang; Shuyu Li; Changhua Shi
Journal:  Front Cell Dev Biol       Date:  2021-12-10

Review 10.  The Nucleus/Mitochondria-Shuttling LncRNAs Function as New Epigenetic Regulators of Mitophagy in Cancer.

Authors:  Yan Li; Wei Li; Andrew R Hoffman; Jiuwei Cui; Ji-Fan Hu
Journal:  Front Cell Dev Biol       Date:  2021-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.